Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Northwest Biotherapeutics (NWBO) Prepaid Assets: 2009-2024

Historic Prepaid Assets for Northwest Biotherapeutics (NWBO) over the last 16 years, with Dec 2024 value amounting to $1.9 million.

  • Northwest Biotherapeutics' Prepaid Assets rose 3.28% to $2.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.3 million, marking a year-over-year increase of 3.28%. This contributed to the annual value of $1.9 million for FY2024, which is 5.60% down from last year.
  • Latest data reveals that Northwest Biotherapeutics reported Prepaid Assets of $1.9 million as of FY2024, which was down 5.60% from $2.0 million recorded in FY2023.
  • In the past 5 years, Northwest Biotherapeutics' Prepaid Assets registered a high of $5.5 million during FY2020, and its lowest value of $1.9 million during FY2024.
  • Moreover, its 3-year median value for Prepaid Assets was $2.0 million (2023), whereas its average is $2.1 million.
  • Its Prepaid Assets has fluctuated over the past 5 years, first skyrocketed by 95.47% in 2020, then plummeted by 61.63% in 2021.
  • Over the past 5 years, Northwest Biotherapeutics' Prepaid Assets (Yearly) stood at $5.5 million in 2020, then tumbled by 61.63% to $2.1 million in 2021, then rose by 15.98% to $2.5 million in 2022, then dropped by 18.74% to $2.0 million in 2023, then declined by 5.60% to $1.9 million in 2024.